Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PAH
Pharma
Insmed's phase 2 PAH win sends stock soaring
The company's treprostinil palmitil inhalation powder is a prodrug of United Therapeutics' blockbuster PAH mainstay Tyvaso.
Zoey Becker
Jun 10, 2025 11:59am
Merck preps filings after Winrevair succeeds in severe PAH study
Nov 25, 2024 9:00am
FDA approves Johnson & Johnson's combo pill Opsynvi for PAH
Mar 25, 2024 11:05am
FDA faces lawsuit from United on its Liquidia review process
Feb 21, 2024 2:31pm
Janssen rounds out final live talk of 2022 for PH nurses
Dec 7, 2022 10:31am
EMA examines key Actelion med Uptravi following 5 patient deaths in France
Feb 14, 2017 10:50am
